Enteritis of the ileal conduit as an adverse event related to immune checkpoint inhibitor use
Inflammation of an ileal conduit can occur as an immune-related adverse event caused by metastatic urothelial carcinoma treatment with pembrolizumab.
Authors
- Toshiaki Tanaka (ORCID: https://orcid.org/0000-0002-1199-9302)
- Ko Kobayashi (ORCID: https://orcid.org/0000-0001-6995-6930)
- Kohei Hashimoto (ORCID: https://orcid.org/0000-0003-0873-4642)
- Naoya Masumori (ORCID: https://orcid.org/0000-0001-6324-0739)
Institutions
- Sapporo Medical University (JP)
Publication Details
- Journal
- IJU Case Reports
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1002/iju5.12797
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.28